Susan Korenchuk

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Medicine, Molecular Genetics, Oncology +15

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 347 citations · Full text

Medicine, Oncology, Pharmacology +7

VCaP, a cell-based model system of human prostate cancer.

Susan Korenchuk, J E Lehr, Lisa L. McLean et al. · PubMed · 2001 · 328 citations

Medicine, Molecular Biology, Oncology +14

Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Mark A. Rubin, MATTHEW J. PUTZI, Neil R. Mucci et al. · PubMed · 2000 · 234 citations

Medicine, Oncology, Pathology +16

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

Anastasia Wyce, Gopinath Ganji, Kimberly N. Smitheman et al. · PLoS ONE · 2013 · 204 citations · Full text

Medicine, Molecular Biology, Oncology +17